Effectiveness of a Pharmacist-Led Web-Based Medication Adherence Tool With Patient-Centered Communication: Results of a Clustered Randomized Controlled Trial

Overview

Journal J Med Internet Res

Publisher JMIR Publications

Specialty Medical Informatics

Date 2022 Apr 7

PMID 35389359

Authors

Jan van Lieshout

Joyca Lacroix

Aart van Halteren

Martina Teichert

Affiliations

Soon will be listed here.

Abstract

Background: Growing numbers of people use medication for chronic conditions; nonadherence is common, leading to poor disease control. A web-based tool to identify an increased risk for nonadherence with related potential individual barriers might facilitate tailored interventions and improve adherence.

Objective: This study aims to assess the effectiveness of a newly developed tool aimed at improving medication adherence.

Methods: We performed a cluster randomized controlled trial in patients initiating cardiovascular or oral blood glucose-lowering medication. Participants were recruited from community pharmacies. They completed an online questionnaire comprising assessments of their risk for medication nonadherence and subsequently of barriers to adherence. In pharmacies belonging to the intervention group, individual barriers displayed in a graphical profile on a tablet were discussed by pharmacists and patients with high nonadherence risk in face-to-face meetings and shared with their general practitioners and practice nurses. Tailored interventions were initiated by pharmacists. Barriers of control patients were not presented nor discussed and these patients received usual care. The primary outcome was the effectiveness of the intervention on medication adherence at 8 months' follow-up between patients with an increased nonadherence risk from the intervention and control groups, calculated from dispensing data.

Results: Data from 492 participants in 15 community pharmacies were available for analyses (intervention 253, 7 pharmacies; control 239, 8 pharmacies). The intervention had no effect on medication adherence (B=-0.01; 95% CI -0.59 to 0.57; P=.96), nor in the post hoc per-protocol analysis (B=0.19; 95% CI -0.50 to 0.89; P=.58).

Conclusions: This study showed no effectiveness of a risk stratification and tailored intervention addressing personal barriers for medication adherence. Various potential explanations for lack of effectiveness were identified. These explanations relate, for instance, to high medication adherence in the control group, study power, and fidelity. Process evaluation should elicit possible improvements and inform the redesign of intervention and implementation.

Trial Registration: The Netherlands National Trial Register NTR5186; https://tinyurl.com/5d8w99hk.

Citing Articles

Surgical Pharmacy for Optimizing Medication Therapy Management Services within Enhanced Recovery after Surgery (ERAS) Programs.

Xie J, Huang X, Gao M, Wei L, Wang R, Chen J J Clin Med. 2023; 12(2).

PMID: 36675560 PMC: 9861533. DOI: 10.3390/jcm12020631.

References

Hamdidouche I, Jullien V, Boutouyrie P, Billaud E, Azizi M, Laurent S . Drug adherence in hypertension: from methodological issues to cardiovascular outcomes. J Hypertens. 2017; 35(6):1133-1144. DOI: 10.1097/HJH.0000000000001299. View

Vrijens B, de Geest S, Hughes D, Przemyslaw K, Demonceau J, Ruppar T . A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012; 73(5):691-705. PMC: 3403197. DOI: 10.1111/j.1365-2125.2012.04167.x. View

Schroeder K, Fahey T, Ebrahim S . Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004; (2):CD004804. PMC: 9036187. DOI: 10.1002/14651858.CD004804. View

Horne R . Patients' beliefs about treatment: the hidden determinant of treatment outcome?. J Psychosom Res. 2000; 47(6):491-5. DOI: 10.1016/s0022-3999(99)00058-6. View

Chew L, Bradley K, Boyko E . Brief questions to identify patients with inadequate health literacy. Fam Med. 2004; 36(8):588-94. View

Krueger K, Berger B, Felkey B . Medication adherence and persistence: a comprehensive review. Adv Ther. 2006; 22(4):313-56. DOI: 10.1007/BF02850081. View

Haynes R, Ackloo E, Sahota N, McDONALD H, Yao X . Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008; (2):CD000011. DOI: 10.1002/14651858.CD000011.pub3. View

Van Driel M, Morledge M, Ulep R, Shaffer J, Davies P, Deichmann R . Interventions to improve adherence to lipid-lowering medication. Cochrane Database Syst Rev. 2016; 12:CD004371. PMC: 6464006. DOI: 10.1002/14651858.CD004371.pub4. View

Elnaem M, Rosley N, Alhifany A, Elrggal M, Cheema E . Impact of Pharmacist-Led Interventions on Medication Adherence and Clinical Outcomes in Patients with Hypertension and Hyperlipidemia: A Scoping Review of Published Literature. J Multidiscip Healthc. 2020; 13:635-645. PMC: 7381776. DOI: 10.2147/JMDH.S257273. View

10.

DOLCE J, Crisp C, Manzella B, Richards J, Hardin J, Bailey W . Medication adherence patterns in chronic obstructive pulmonary disease. Chest. 1991; 99(4):837-41. DOI: 10.1378/chest.99.4.837. View

11.

Erkens J, Panneman M, Klungel O, van den Boom G, Prescott M, Herings R . Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Pharmacoepidemiol Drug Saf. 2005; 14(11):795-803. DOI: 10.1002/pds.1156. View

12.

Hilbink M, Lacroix J, Bremer-van der Heiden L, van Halteren A, Teichert M, van Lieshout J . Effectiveness of a medication-adherence tool: study protocol for a randomized controlled trial. Trials. 2016; 17(1):274. PMC: 4891916. DOI: 10.1186/s13063-016-1393-2. View

13.

Friedman J, Hastie T, Tibshirani R . Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010; 33(1):1-22. PMC: 2929880. View

14.

Zomahoun H, de Bruin M, Guillaumie L, Moisan J, Gregoire J, Perez N . Effectiveness and Content Analysis of Interventions to Enhance Oral Antidiabetic Drug Adherence in Adults with Type 2 Diabetes: Systematic Review and Meta-Analysis. Value Health. 2015; 18(4):530-40. DOI: 10.1016/j.jval.2015.02.017. View

15.

Blaschke T, Osterberg L, Vrijens B, Urquhart J . Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol. 2011; 52:275-301. DOI: 10.1146/annurev-pharmtox-011711-113247. View

16.

Horne R, Chapman S, Parham R, Freemantle N, Forbes A, Cooper V . Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013; 8(12):e80633. PMC: 3846635. DOI: 10.1371/journal.pone.0080633. View

17.

Jamous R, Sweileh W, El-Deen Abu Taha A, Zyoud S . Beliefs About Medicines and Self-reported Adherence Among Patients with Chronic Illness: A Study in Palestine. J Family Med Prim Care. 2014; 3(3):224-9. PMC: 4209677. DOI: 10.4103/2249-4863.141615. View

18.

Omboni S, Caserini M . Effectiveness of pharmacist's intervention in the management of cardiovascular diseases. Open Heart. 2018; 5(1):e000687. PMC: 5761304. DOI: 10.1136/openhrt-2017-000687. View

19.

Fuller R, Perel P, Navarro-Ruan T, Nieuwlaat R, Haynes R, Huffman M . Improving medication adherence in patients with cardiovascular disease: a systematic review. Heart. 2018; 104(15):1238-1243. DOI: 10.1136/heartjnl-2017-312571. View

20.

Haynes R, Taylor D, Sackett D, Gibson E, Bernholz C, Mukherjee J . Can simple clinical measurements detect patient noncompliance?. Hypertension. 1980; 2(6):757-64. DOI: 10.1161/01.hyp.2.6.757. View